- Charitable Donations to registered Charities and Non-Governmental Organizations (“NGO”) – or, in specific instances, to patients - for indigent care and, occasionally, emergency relief under LivaNova’s Corporate Social Responsibility program “LIFE”;
- Educational Grants to Healthcare Organizations, Patient Organizations, Professional Conference Organizers, schools or other educational centers for (a) medical education or training initiatives for healthcare staff, e.g. training courses, fellowships, scholarships, Third Party Organized Educational Events (“TPOEE”) such as medical congresses or conferences organized by national, regional, or specialty medical associations/societies, hospitals, Professional Conference Organizers, Patient Organizations or accredited Continuing Medical Education (“CME”) providers, or (b) general education / awareness initiatives for patients, care-givers, students, communities and the general public, e.g. public awareness campaigns;
- Research Grants to Healthcare Organizations for independent research projects that serve a genuine medical-scientific purpose in the Neuromodulation or Cardiopulmonary field and that do not involve any LivaNova product, brand or influence. A Research Grant is made for the sole, restrictive purpose of supporting the development or furtherance of Bona Fide, scientifically valid and legitimate research by the Requesting Party, the aim of which is to advance medical, scientific and Healthcare knowledge, medical technologies and/or clinical techniques designed to improve patient outcomes.
PLEASE NOTE: Requests that relate to Investigator Initiated Research or "IIRs" (i.e. research that involves LivaNova devices) or Commercial Sponsorship (i.e. quid-pro-quo arrangements that are commercial in nature, e.g. the purchase of a booth, industry-sponsored promotional sessions, exhibitor space, etc.) are NOT within the scope of LivaNova's Donations and Grants Program. For these requests, please visit our dedicated IIR page and our dedicated Commercial Sponsorship page.